Medpace Holdings, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveAug 14 →InsidersNo open-market buys. 7 insiders sold $258.5M, 1 of 27 sales on a 10b5-1 plan.→HoldersBlackRock 9.0%AQR 4.6%Vanguard Portfolio 4.1%→PeersClosest companies: FTRE, CERT, NEO→
From the filings
Figures
- Revenue
- $2.78Blast 12 months
- Net income
- $491.5Mlast 12 months
- Operating cash flow
- $739.2Mlast 12 months
- Cash and equivalents
- $502.7Mat the last balance sheet
- Shares outstanding
- 27.9M shareson issue